On this episode of The Pulse, brought to you by MDT TV, we are regenerating limbs, building better brain implants, engineering 3D tissue, and measuring consciousness.
TissueTech Inc. said it pulled down $10 million from a pair of venture capital shops to back its regenerative medicine subsidiaries, Bio-Tissue and Amniox Medical. The equity round came from Ballast Point Ventures and River Cities Capital Funds, according to a press release.
Anxiety disorders, which include posttraumatic stress disorder, social phobias and obsessive-compulsive disorder, affect 40 million American adults in a given year. To develop better treatments, a more specific understanding of the brain circuits that produce anxiety is necessary.
California medical device maker ResMed (NYSE:RMD) is taking another swing at Chinese respiratory technology rival BMC Medical, getting the International Trade Commission's cooperation in an investigation into potential patent infringement.
Researchers in India have carried out a data mining exercise to determine which are the most important risk factors in increasing the chances of an individual suffering a heart attack. The use of computational data mining techniques that allow researchers to extract interesting and meaningful information from real-life clinical data could remove at least some aspect of the subjectivity of clinical prognosis.
Clean drinking water is a diminishing natural resource in developing nations and in many industrialized countries. VTT Technical Research Centre of Finland has developed a simple and inexpensive test kit that detects phenolic compounds in water.
Boston Scientific Corporation continues to expand its electrophysiology (EP) offerings with U.S. Food and Drug Administration (FDA) approval of its IntellaTip MiFi™ XP catheter and 510(k) clearance of its Zurpaz™ 8.5F steerable sheath.
Until now, surgeons have had to memorize the precise location of important blood vessels in organs and where tumors could likely be found and need to be removed. A new app for tablet computers developed by Fraunhofer MEVIS in Bremen could support surgeons in the future and help them reduce the rate of complications during operations.
The Japanese Market For Peripheral Vascular Devices Will Be Characterized By New Product Launches In Many SegmentsAugust 22, 2013 8:00 am | by PR Newswire | News | Comments
According to Millennium Research Group, the global authority on medical technology market intelligence, efforts to streamline the regulatory approval process in Japan have resulted in the recent entry of numerous devices in the Japanese peripheral vascular (PV) device market, and more products, such as drug-coated balloons and infrapopliteal stents, are expected to enter in the next few years.
C.R. Bard settled the 2nd bellwether trial over its Avaulta pelvic mesh just before it was supposed to go to trial, a week after losing a $2 million judgment in the 1st trial. Murray Hill, N.J.-based Bard and plaintiff Wanda Queen agreed to settle the case on undisclosed terms...
Many medical device companies have long petitioned for a repeal of the 2.3% excise tax on U.S. sales, but analysts say medtech companies have already managed to absorb the tax without taking a hit to the bottom line or jacking up costs for consumers.
Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that it has received a $25 million equity investment from Nipro Corporation. This investment builds on Infraredx’s exclusive agreement with Nipro for distribution of its TVC Imaging System in Japan, the world’s largest intravascular imaging market.
No, hyperbaric oxygen therapy (HBOT) has not been clinically proven to cure or be effective in the treatment of cancer, autism, or diabetes. But do a quick search on the Internet, and you'll see all kinds of claims for these and other diseases for which the device has not been cleared or approved by FDA.
In early human tests, SetPoint Medical has found that an electronic implant helped reduce the symptoms of rheumatoid arthritis in six of eight patients. The company is one of many groups exploring the potential of electronic implants to treat diseases by delivering pulses to nerves that regulate organ or body functions.
No. 836 is a 750OF electrically-heated Class 100 cleanroom oven from Grieve, currently used to bake various coatings onto products at a customer’s facility. Workspace dimensions of this oven measure 36” wide x 36” deep x 39” high.